|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03681 SINOMAB BIO-B
Nominal 
1.180 -0.040 (-3.279%) | 2025/12 - Final RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | (70,478) | (130,801) | (133,847) | (300,538) | (147,063) |
| Net Cash from / (used in) Investing Activities | 16,251 | (94,482) | (96,921) | (81,358) | (137,702) |
| Net Cash from / (used in) Financing Activities | 329,388 | 73,268 | 82,267 | 102,285 | 57,515 |
| Increase / (Decrease) in Cash & Cash Equivalents | 275,161 | (152,015) | (148,501) | (279,611) | (227,250) |
| Cash & Cash Equivalents at beginning of period | 61,900 | 203,664 | 342,887 | 562,983 | 810,370 |
| Effect of Foreign Exchange Rate Changes | (14,353) | 10,251 | 9,278 | 59,515 | (20,137) |
| Others | 0 | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 322,708 | 61,900 | 203,664 | 342,887 | 562,983 |
| Remarks: | Real time quote last updated: 04/06/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -104,985 |
| %Change | -43.295% |
| EPS / (LPS) | RMB -0.090 |
| NBV Per Share (¥) | RMB 0.366 |